PRMT6 and glioblastoma: Importantly, our initial experiments demonstrate that a small molecule inhibitor of PRMT6 (EPZ020411) exhibits promising anti-invasive effects on glioblastoma cells in vitro, suggesting the potential for targeted therapy.